Cargando…

MiR-215-5p is a tumor suppressor in colorectal cancer targeting EGFR ligand epiregulin and its transcriptional inducer HOXB9

Growing evidence suggests that microRNAs are involved in the development and progression of colorectal cancer (CRC). In the present study, deregulation and functioning of tumor-suppressive miR-215-5p was evaluated in CRC. In total, 448 tumor tissues and 325 paired adjacent healthy tissues collected...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vychytilova-Faltejskova, Petra, Merhautova, Jana, Machackova, Tana, Gutierrez-Garcia, Irene, Garcia-Solano, José, Radova, Lenka, Brchnelova, Dominika, Slaba, Katerina, Svoboda, Marek, Halamkova, Jana, Demlova, Regina, Kiss, Igor, Vyzula, Rostislav, Conesa-Zamora, Pablo, Slaby, Ondrej
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5868056/ https://www.ncbi.nlm.nih.gov/pubmed/29199273 http://dx.doi.org/10.1038/s41389-017-0006-6

Ejemplares similares

MiR-215-5p Reduces Liver Metastasis in an Experimental Model of Colorectal Cancer through Regulation of ECM-Receptor Interactions and Focal Adhesion
por: Machackova, Tana, et al.
Publicado: (2020)

miR-155 and miR-484 Are Associated with Time to Progression in Metastatic Renal Cell Carcinoma Treated with Sunitinib
por: Merhautova, Jana, et al.
Publicado: (2015)

MicroRNA Biogenesis Pathway Genes Are Deregulated in Colorectal Cancer
por: Vychytilova-Faltejskova, Petra, et al.
Publicado: (2019)

Identification and functional screening of microRNAs highly deregulated in colorectal cancer
por: Faltejskova, Petra, et al.
Publicado: (2012)

MicroRNA expression profiling identifies miR-31-5p/3p as associated with time to progression in wild-type RAS metastatic colorectal cancer treated with cetuximab
por: Mlcochova, Jitka, et al.
Publicado: (2015)

Mutational analysis of primary and metastatic colorectal cancer samples underlying the resistance to cetuximab-based therapy
por: Nemecek, Radim, et al.
Publicado: (2016)

Epithelial-mesenchymal transition-associated microRNA/mRNA signature is linked to metastasis and prognosis in clear-cell renal cell carcinoma
por: Mlcochova, Hana, et al.
Publicado: (2016)

MicroRNA expression profile associated with response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients
por: Svoboda, Marek, et al.
Publicado: (2012)

MicroRNA-Based Therapy in Animal Models of Selected Gastrointestinal Cancers
por: Merhautova, Jana, et al.
Publicado: (2016)

Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma
por: Redova, Martina, et al.
Publicado: (2012)

Akt expression and compartmentalization in prediction of clinical outcome in HER2-positive metastatic breast cancer patients treated with trastuzumab
por: GRELL, PETER, et al.
Publicado: (2012)

MicroRNA isolation and quantification in cerebrospinal fluid: A comparative methodical study
por: Kopkova, Alena, et al.
Publicado: (2018)

Decreased expression levels of PIWIL1, PIWIL2, and PIWIL4 are associated with worse survival in renal cell carcinoma patients
por: Iliev, Robert, et al.
Publicado: (2016)

Common polymorphisms in GSTM1, GSTT1, GSTP1, GSTA1 and susceptibility to colorectal cancer in the Central European population
por: Hezova, Renata, et al.
Publicado: (2012)

The Impact of Diabetes Mellitus on the Second Primary Malignancies in Colorectal Cancer Patients
por: Halamkova, Jana, et al.
Publicado: (2021)

Long non-coding RNA ZFAS1 interacts with CDK1 and is involved in p53-dependent cell cycle control and apoptosis in colorectal cancer
por: Thorenoor, Nithyananda, et al.
Publicado: (2015)

Epigenetic Regulation of MicroRNA Clusters and Families during Tumor Development
por: Gregorova, Jana, et al.
Publicado: (2021)

MicroRNAs in colorectal cancer: translation of molecular biology into clinical application
por: Slaby, Ondrej, et al.
Publicado: (2009)

Genetic polymorphisms and microRNAs: new direction in molecular epidemiology of solid cancer
por: Slaby, Ondrej, et al.
Publicado: (2012)

MiR-21, miR-34a, miR-198 and miR-217 as diagnostic and prognostic biomarkers for chronic pancreatitis and pancreatic ductal adenocarcinoma
por: Vychytilova-Faltejskova, Petra, et al.
Publicado: (2015)

Second primary malignancies in colorectal cancer patients
por: Halamkova, Jana, et al.
Publicado: (2021)

LncRNAs LY86-AS1 and VIM-AS1 Distinguish Plasma Cell Leukemia Patients from Multiple Myeloma Patients
por: Bútová, Romana, et al.
Publicado: (2021)

MicroRNAs as outcome predictors in patients with metastatic colorectal cancer treated with bevacizumab in combination with FOLFOX
por: Kiss, I., et al.
Publicado: (2017)

Expression of miRNA-106b in conventional renal cell carcinoma is a potential marker for prediction of early metastasis after nephrectomy
por: Slaby, Ondrej, et al.
Publicado: (2010)

Expression of miRNA-106b in conventional renal cell carcinoma is a potential marker for prediction of early metastasis after nephrectomy
por: Slaby, Ondrej, et al.
Publicado: (2010)

Efficacy of bevacizumab and chemotherapy in the first-line treatment of metastatic colorectal cancer: broadening KRAS-focused clinical view
por: Bencsikova, Beatrix, et al.
Publicado: (2015)

Cerebrospinal Fluid MicroRNA Signatures as Diagnostic Biomarkers in Brain Tumors
por: Kopkova, Alena, et al.
Publicado: (2019)

Involvement of Small Non-Coding RNA and Cell Antigens in Pathogenesis of Extramedullary Multiple Myeloma
por: Vlachová, Monika, et al.
Publicado: (2022)

Prediction of response to anti-EGFR antibody-based therapies by multigene sequencing in colorectal cancer patients
por: Lupini, Laura, et al.
Publicado: (2015)

Novel classes of non-coding RNAs and cancer
por: Sana, Jiri, et al.
Publicado: (2012)

The food web in a subterranean ecosystem is driven by intraguild predation
por: Parimuchová, Andrea, et al.
Publicado: (2021)

Everolimus-related unilateral abdominal lymphedema in a renal cancer patient: A case report
por: Halamkova, Jana, et al.
Publicado: (2020)

MiR-34b is associated with clinical outcome in triple-negative breast cancer patients
por: Svoboda, Marek, et al.
Publicado: (2012)

Translational Potential of MicroRNAs for Preoperative Staging and Prediction of Chemoradiotherapy Response in Rectal Cancer
por: Machackova, Tana, et al.
Publicado: (2019)

The risk of second primary malignancies in colorectal cancer patients using calcium channel blockers
por: Halámková, Jana, et al.
Publicado: (2023)

Stress-Induced Neuroprotective Effects of Epiregulin and Amphiregulin
por: Zhan, Libin, et al.
Publicado: (2015)

Combination of MiR-378 and MiR-210 Serum Levels Enables Sensitive Detection of Renal Cell Carcinoma
por: Fedorko, Michal, et al.
Publicado: (2015)

MicroRNAs and glioblastoma: roles in core signalling pathways and potential clinical implications
por: Sana, Jiri, et al.
Publicado: (2011)

Use of Hypolipidemic Drugs and the Risk of Second Primary Malignancy in Colorectal Cancer Patients
por: Halámková, Jana, et al.
Publicado: (2022)

MicroRNAs as theranostic markers in cardiac allograft transplantation: from murine models to clinical practice
por: Novák, Jan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_c1hes9v7n2gjup38s9ssul3tpd